cannabinoid信息详情
n.大麻素（大麻中的任意化学成分）
Cannabinoid production starts when an enzyme causes geranyl pyrophosphate and olivetolic acid.───当一种酶引起香叶酰焦磷酸盐和胆酸时，大麻素的生产就开始了。
The present application relates to cannabinoid receptor ligands containing compounds of formula (I) wherein a, R1, R2, and R3 are as defined in the specification.───本申请涉及含有式(i)化合物的大麻素受体配体，其中A、R 1、R2和R3如说明书中所定义。
Also disclosed are pharmaceutical compositions and combinations containing said compounds and their USES as thrombin receptor antagonists and binders to cannabinoid receptors.───本发明还公开了含有所述化合物的药物组合物和药物联用以及它们用作凝血酶受体拮抗剂和类大麻醇受体结合剂的用途。
Recently drugs that act on cannabinoid receptors- the ones that mediate marijuana's effects- have been advancing through clinical trials.───最近，作用于大麻素受体的药物也进入了临床试验；大麻素受体是大麻在人体内作用的位置。
And we learn that the body contains a network of cannabinoid receptors that modulate pain, appetite and short-term memory.───我们也了解到人的身体里有一个大麻成分受体的网络，能够调整痛感，食欲和短期记忆。
It turns out that sweetness receptors are present in the same cells as cannabinoid receptors on our tongues.───原来这是因为我们舌头上甜味的受体与大麻素的受体处于同种细胞里。
So in fibrotic livers you can find cannabinoid receptors that have both anti- and pro-fibrogenic effects.───因此在发生纤维化的肝脏大麻素受体既有抗纤维化作用也有促纤维化作用。
One promising approach is the use of the selective cannabinoid type 1 receptor antagonist rimonabant.───一个有前途的方法是使用选择性大麻素1型受体拮抗剂利莫那班。
Rimonabant belongs to the new drug class of cannabinoid-1 receptor antagonists.───利莫那班属于新的药物类大麻-1受体拮抗剂。
Sativex contains approximately equal amounts of THC and the non-psychoactive plant cannabinoid, cannabidiol.